Why GSX stock soared? Short-sellers are getting squeezed.......The coronavirus is getting worse in China, and it's possible that investors believe that's a good thing for GSX.
GSX is a remote-education company in China, and its business grew substantially in 2020. And if COVID-19 gets worse in that country, it's possible 2021 will be another good year for this business.
According to The Associated Press, new coronavirus cases are causing the Chinese government to lock down two hospitals in Shanghai.
it appears investors might expect GSX Techedu's services will be in greater demand if the pandemic worsens in China.
This is further complicated by short interest in this stock. According to Yahoo! Finance, around half of the stock's float was sold short up until recently. If investors are buying shares over the last few days because of the news coming out of China, it could be causing a short squeeze, as short-sellers are forced to cover their bearish positions.
Over 22% of GSX stock is sold short, giving it a short interest ratio of almost 14 days (anything over seven days is considered a lot). While that indicates short-sellers are getting squeezed, or being forced to cover their positions at ever-higher prices, it's more just a phenomenon flooding the market at the moment.
the company is under fire from many popular short-sellers, who claim GSX Techedu is a fraud.
And the company has indeed admitted that it is under investigation from the Securities and Exchange Commission (SEC). While that investigation is ongoing and it may turn out that everything is above board, this has caused a lot of people to actively bet against this stock.
The company faces the possibility of being delisted from major U.S. exchanges if the SEC finds wrongdoing. Therefore, it's important to approach a GSX Techedu investment fully aware of this risk.
Investors shouldn't be swayed by these price swings, and investors would be smart to sit on the sidelines until GSX Techedu sorts out the battle taking place between short-sellers and those long on its stock.
www.fool.com
Stockstotrade
Overstock to be limited partner in blockchain fundOverstock Partners with Pelion Venture Partners to Oversee Medici Ventures’ Blockchain Assets
Overstock to be limited partner in blockchain fund
OSTK today announces it will be converting Medici Ventures, Inc., its wholly owned blockchain-focused subsidiary, to a limited partnership (the “Fund”). An entity within Pelion Venture Partners, a third-party venture capital firm with a proven track record of successfully investing in early stage companies, will act as the general partner of the Fund.
Pelion has blockchain and technology expertise with early stage companies and has helped guide many companies to economic success.
Under the arrangement, which will close after obtaining necessary legal and regulatory approvals, Medici Ventures will be converted into a limited partnership.
finance.yahoo.com
CVLB Expects 2020 Revenue up 205% to Record $38.0 MillionConversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million
preliminary unaudited results for its fourth quarter and full year ended December 31, 2020.
Revenue for the fourth quarter is expected to total $13.6 million, up 265% from $3.7 million in the fourth quarter of 2019. Revenue for the full year is expected to total $38.0 million, up 205% from $12.5 million in 2019.
We ended the year exceptionally strong, with December revenues hitting a monthly record of $5.1 million, up 321% over December of last year. In fact, December 2020 alone eclipsed the whole of the fourth quarter of 2019.”
ual recurring revenue (ARR) generated by subscriptions reached $26.0 million by the end of the year, up 525% compared to the end of 2019 (see description of ARR, below). ARR increased by more than $3.0 million from November to December—another record-setting monthly gain.
“Given our extensive telehealth platform buildout in 2019, we were prepared when the breakout of the COVID-19 pandemic suddenly accelerated the consumer shift from traditional healthcare to telemedicine,”
expect 2021 to be our biggest year yet.”
finance.yahoo.com
Equity Investment and Strategic Business CooperationBaozun and iClick Announce Equity Investment and Strategic Business Cooperation
As a result of the agreement, Baozun will own 4% of iClick's shares outstanding and control 10% of its voting power.
The companies said they entered into a "strategic cooperation framework agreement" and will collaborate on a closed-loop e-commerce service model, focusing on areas like digital marketing, customer service, and fulfillment. That complements Baozun's core business of providing e-commerce services such as marketing, fulfillment, and IT for multinational companies like Microsoft and Nike. Also key in the deal is that both companies will develop a private domain traffic platform for Tencent, the tech giant and owner of the super-app WeChat.
A short squeeze may have also helped drive the shares higher.
Baozun is subject to a 180-day lock-up period on the above shares subscribed from iClick or purchased from the existing shareholder.
finance.yahoo.com
Pfizer forming a double bottom to continue moving up?Another update on PFE. Price has stalled for some time now around the internal support. We have a divergence with RSI and the price and RSI is starting to move above 50. MACD is making a bullish crossing and the histogram is going positive as well. Volumes are showing buying activity and we have a potential setup for a double bottom. Keep an eye on PFE.
Bank of America in risk of a trend reversalMy bearish view for Bank of America is almost confirmed. All is left is a move below $30.59 zone. RSI and MACD are flashing red and point for a continuation of the selling. Volumes are descending as activity is slowing down resent days.
Since the bad earnings, the bank is under pressure from investors, but still the downtrend is not entirely confirmed. Given the broader market and perpetual stimulus, BAC may have a second chance to continue its uptrend.
PBI jumps on positive pitch from Seeking Alpha contributorPitney Bowes jumps on positive pitch from Seeking Alpha contributor
Pitney Bowes (NYSE:PBI) gains 40% after a Seeking Alpha contributor writes that the stock is "significantly" undervalued vs competitors and a break up or sale of company would unlock value.
Expects PBI's global e-commerce business to be profitable for first time ever when earnings are released on Feb. 2.
Highlights that Legendary investor Bill Miller owns PBI and believes e-commerce segment on a standalone basis is worth $12/share, citing 3Q Miller investor letter.
PBI short interest "nearly" 20% of float
www.reddit.com
operating income increase of 527%The company reported revenues of $191.7 million, net income of $10.9 million, and basic EPS (earnings per share) of $6.40. The company also reported operating income of $20.4 million, representing an increase of 527% over the same period last year. During the 2020 fiscal year, the company repurchased 236,908 shares of its common stock at an average price of $7.01 per share.
At September 30, 2020, the company reported total assets of $197.2 million and total liabilities of $153.5 million. Stockholders’ equity stood at $43.9 million, or $25.75 per basic common share1. At September 30, 2020, the company had cash and availability under its various lines of credit $37.7 million.
The Company completed two significant acquisitions in 2020, Lonesome Oak in January and Precision Marshall in July.
CymaBay Therapeutics $CBAY - investment idea 💡 ❌ - The volume is low on daily but increasing on 4h
✅ - We got double bottom on daily
✅ - We got Bullish engulfing action few days back on the lower channel at $5.64
✅ - MACD
✅ - STOCH
✅ - DeMarker
❌ - MA50 (13% under 50MA)
✅ - MA200 (6% above 200MA)
❌ - Pivots: (7% under the pivot point)
✅ - Ratings (7) buy
⏰ - Breakout 1: $6, Breakout 2: $6.40
🚀 - Potential targets (🚀+45%, 🚀🚀+81%, 🚀🚀🚀+107%)
🪂 - If things goes wrong better to exit under 5.62
🚦 - Next entries in case if dropped: $5.12, $4.20
⚠️ - This idea is based on my technical analysis only. Do your research and trade on your own risk!
--
Is CBAY A Good Stock To Buy Now?
finance.yahoo.com
CymaBay Therapeutics Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com
at-the-market offering for up to $35,000,000On January 25, 2021, IZEA Worldwide, Inc. (the “Company”) launched an at-the-market offering (the “Offering”) for up to $35,000,000 worth of shares of the Company’s common stock, par value $0.0001 per share, pursuant to an at the market (ATM) Sales Agreement, dated January 25, 2021, by and between the Company and National Securities Corporation. A copy of the ATM Sales Agreement is attached hereto as Exhibit 1.1 and is incorporated by reference herein.
The Company has 54,526,583 shares of common stock outstanding as of January 25, 2021.
Secondary stock offerings normally aren't a reason for shareholders to celebrate, but investors seem to see this one as a smart way for IZEA to raise cash it can use to fund additional growth efforts, as well as a validation of the stock's recent surge. The sale would dilute current shareholders by about 10%.
In 2019, the company's revenue declined 6% to $19 million and it lost $7.3 million.
If new products like Shake and its BrandGraph intelligence platform take off, the stock should have more room to run.
www.sec.gov
OSS as exclusive EPC for North American Solar ProjectsOrbital Energy Group's Subsidiary, Orbital Solar Services, Partners with Black Sunrise Half Century Fund and Akon Lighting America as exclusive EPC for North American Solar Projects.
OEG), today announced that its wholly-owned subsidiary, Orbital Solar Services ("OSS"), a leader in utility-scale solar power generation facilities, has been named the engineering, procurement, and construction ("EPC") company "of choice" for the newly-formed Black Sunrise Half Century Fund.
As announced by Akon last Wednesday at President Biden's "Clean Energy for America" Inaugural Ball (Clean Energy Ball), OSS is partnering with Akon, Akon Lighting America (Akon Lighting), and the Black Sunrise Half Century Fund to decommission coal-fired power plants throughout the United States and convert them into utility-scale solar energy farms.
OSS is responsible for providing full EPC services for these solar facilities, beginning in the second quarter of 2021.
In selecting OSS and Orbital Energy Group as its EPC company of choice, BSF considered OSS's technical, innovation and support capabilities. This includes OSS's proven track record of success in executing over 40 solar projects in excess of 600 megawatts, with more than 50 years combined experience in the delivery and management of both commercial and renewable energy construction projects.
finance.yahoo.com
Aemetis “Carbon Zero” Supported by $16.8 MillionAemetis “Carbon Zero” Solar Energy and Energy Efficiency Upgrades Supported by $16.8 Million of California CEC and Utility Grants
Estimated $18 Million Per Year of Increased Net Income ($0.75 Earnings Per Share)
AMTX) announced that its “Carbon Zero” biofuels production process has received a total of $16.8 million of solar energy and other energy efficiency grants to fund upgrades of the Keyes, California plant to support the production of zero carbon renewable fuel.
The award of a combined $16.8 million of California Energy Commission and Pacific Gas & Electric energy efficiency programs to fund the ‘Carbon Zero 1’ biofuels plant reflects government and utility industry support for our mission to reduce greenhouse gases
These Carbon Zero plant upgrades at the Keyes plant are an integrated part of producing below zero carbon biofuels from agricultural waste wood.
The Carbon Zero 1 plant renewable energy and energy efficiency upgrades include funding and other support from the California Energy Commission, the USDA, the US Forest Service, the California Department of Food and Agriculture, and PG&E.
finance.yahoo.com
U.S. Patent Trial and Appeals Board Affirms ValidityU.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
announced today that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued a decision upholding the validity of all claims of U.S. Patent No. 10,195,214, “Concomitant Administration of Glucocorticoid Receptor Modulators and CYP3A Inhibitors” (the “‘214 patent”). The ‘214 patent expires in 2037.
finance.yahoo.com
Successful field testing of prototype lines of the oilseedYield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
today announced successful field testing of prototype lines of the oilseed Camelina sativa that have been programed to produce PHA bioplastics directly in seed.
PHA are natural polymers, prevalent in nature and fully biodegradable in the environment.
PHA bioplastics could ultimately be used to manufacture a wide range of fully biodegradable consumer products.
The prototype plants tested in these studies were programed with microbial genes based on a recent patent filed for new technology developed by Yield10 researchers to produce Camelina seed containing high levels of PHA bioplastic suitable for field production.
finance.yahoo.com
SYMJEPI Products Now Available in the WalgreensSYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
ADMP) today announced that its SYMJEPI® (epinephrine) Injection products are now available to members of the Walgreens Prescription Savings Club program, for a discounted price of $99.99 for a two-pack, the lowest price offered for epinephrine products through the Walgreens Prescriptions Savings Club, and the lowest price for epinephrine devices on the market1.
finance.yahoo.com
Express, Inc. Announces $140 Million in Additional FinancingExpress, Inc. Announces $140 Million in Additional Financing to Bolster Liquidity
EXPR today announced that it has entered into a definitive loan agreement with Sycamore Partners as lead lender, along with Wells Fargo and Bank of America Merrill Lynch, that strengthens its liquidity position by an additional $140 million.
The new financing includes a $90 million FILO Term Loan with a maturity date of May 24, 2024, and a $50 million Delayed Draw Term Loan, to be repaid upon receipt of a CARES Act tax refund expected to be received in the second quarter of 2021.
This financing is in addition to the Company’s existing $250 million asset-based loan facility, of which it had previously drawn $165 million.
finance.yahoo.com
A 1 bill Val a 9$ price targetTwitter hyping: A 1 bill Val a 9$ price target by ARGUS research
twitter.com
GME Record Surge Gives Win to Reddit Army in Citron ClashGameStop Record Surge Gives Win to Reddit Army in Citron Clash
In the battle between short-seller Citron Research and an army of Reddit-charged day traders, GameStop Corp.’s seemingly endless rally to an all-time high has given the stock’s bulls a win, though not without controversy.
GameStop’s 75% gain through Friday comes after it more than doubled the week before and marks the most volatile 10-day period on record, data compiled by Bloomberg show. The stock was halted at least four times in New York as it surged as much as 79% to $76.76 as Reddit users ran wild. It was last 44% higher after trading resumed.
At one point, the video-game retailer was the most actively traded U.S. company with a market value above $200 million, data compiled by Bloomberg show, as millions of shares exchanged hands every few minutes.
GameStop representatives didn’t return an email seeking comment.
Reddit users continued to pump up their bets with one user saying they relied on it to pay their student loans.
GameStop’s parabolic rise, which has come amid steady and elevated short interest and increasing volume, has showcased the divide between retail bulls and bears betting on a quick return to reality.
GameStop became a “cult stock because of Ryan Cohen’s success with Chewy” and retail investors “appear confident that he can implement omnichannel initiatives that will materially grow their earnings,” Wedbush analyst Michael Pachter said in an email.
For the company to be worth $50 a share it would have to quickly double their growth, Pachter, who has a $16 price target which is the second highest among analyst tracked by Bloomberg, continued. In order to give GameStop credit for higher earnings power, Pachter, who rates the stock at neutral, wants to see Cohen’s strategy.
A backlash against Citron by some vocal Reddit users over its views on GameStop came to a head on Friday when the short seller said it will stop commenting on the stock following the actions of “an angry mob.”
“We are investors who put safety and family first and when we believe this has been compromised, it is our duty to walk away from a stock,” Citron managing partner Andrew Left wrote in a Friday letter.
The statement came a day after Left said in a YouTube video that he’d “never seen such an exchange of ideas of people so angry about someone joining the other side of a trade,” referring in part to Reddit users who have been particularly vocal on the social media site in seeking to promote their positive opinions on the video-game retailer’s stock.
GameStop fans clashed with Citron after the short seller critiqued shares in a tweet on Tuesday and made plans for a Twitter Inc. livestream the following day. The event was initially pushed back for the inauguration of President Joe Biden and then again on Thursday due to attempts to hack the short-seller’s Twitter account.
credited the bulk of last week’s gains to a short squeeze after activist investor and Chewy Inc. co-founder Ryan Cohen was added to GameStop’s board.
Bearish bets have remained steady with 140% of available GameStop shares currently sold short, according to data compiled by S3 Partners. Bears have seen more than $1.74 billion mark-to-market losses this year, according to the financial analytics firm.
“While older existing shorts have been covering some of their positions due to a profit-loss based short squeeze, there is a queue of new short sellers wanting to get short exposure in GME after its recent run-up,” Ihor Dusaniwsky, S3’s managing director of predictive analytics, said by email.
AzurRx BioPharma Announces First Two Patients DosedAzurRx BioPharma Announces First Two Patients Dosed in Phase 2b OPTION 2 Extension Study of MS1819 in Cystic Fibrosis Patients
Due to enrollment in the initial crossover trial being ahead of schedule, we are given an opportunity to thoroughly explore optimal doses and capsule types that will help guide our future development plans for MS1819 in a Phase 3 program. In the meantime, we will continue our preparation for a successful FDA meeting later this year.”
Topline data results for this study are anticipated in Q1 2021, as enrollment remains strong.
finance.yahoo.com
EVgo to Publicly List through CLII spac companyEVgo, an LS Power Company, and Leader in U.S. Electric Vehicle Fast Charging, to Publicly List through Business Combination with Climate Change Crisis Real Impact I Acquisition Corporation
Anticipated net proceeds of approximately $575 million will be used to fully fund and accelerate EVgo’s growth strategy and network buildout. This includes a $400 million fully committed private placement of common stock in EVgo (the “PIPE”). The PIPE is anchored by institutional investors including private funds affiliated with Pacific Investment Management Company LLC (PIMCO), funds and accounts managed by BlackRock, Wellington Management, Neuberger Berman Funds and Van Eck Associates Corporation.
CRIS is co-sponsored by private funds affiliated with PIMCO, which has more than $640 billion in sustainability investments across its portfolios.
Commercial relationships with large automotive OEMs (including General Motors, Nissan and Tesla), rideshare operators (including Lyft and Uber), and major property owners for its host sites (including Albertsons, Wawa, and Kroger), underscore EVgo’s market-leading position in the rapidly growing fast charging market.
LS Power, a leading investment firm focused on power, energy infrastructure and energy innovation, along with EVgo management, who together own 100% of EVgo today, will be rolling 100% of their equity in the transaction and are expected to own approximately 74% of the company upon transaction close.
Pro forma implied equity value of the combined company of $2.6 billion. The transaction is expected to close in the second quarter of 2021, subject to customary closing conditions.
With more than 800 locations in 67 major metropolitan markets across 34 states, EVgo’s network serves a rapidly expanding customer base that currently exceeds 220,000 customers.
a strategic relationship with General Motors, which selected EVgo for a nationwide EV charging infrastructure buildout, whereby EVgo expects to add more than 2,700 additional fast chargers to its network over the next 5 years.
Corporate partners also include Uber and Lyft, which selected EVgo as one of their first charging providers.
EVgo has also worked with Tesla, to enable native fast charging on EVgo’s network.
www.businesswire.com
Termination of a Material Definitive AgreementInvestors appear to be responding to the company filing an 8-K today, which seems to indicate that there will be no dilution. This news went viral on a number of stock trading forums including StockTwits.
Termination of a Material Definitive Agreement.
On January 20, 2021, the Company delivered notice to Lincoln Park Capital Fund, LLC, an Illinois limited liability company (“Lincoln Park Capital”) terminating the Purchase Agreement, dated September 8, 2020 (the “2020 Purchase Agreement”), with Lincoln Park Capital effective January 21, 2021 (the “Termination Date”). The 2020 Purchase Agreement provided that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right to sell to Lincoln Park Capital up to $26 million of shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), over the 36-month term of the 2020 Purchase Agreement. In consideration for entering into the 2020 Purchase Agreement, the Company issued to Lincoln Park Capital 437,828 shares of the Company’s Common Stock.
sec.report
pulse2.com